Karyopharm Therapeutics, Inc. (KPTI)
1.73
-0.02
(-1.14%)
USD |
NASDAQ |
Sep 24, 16:00
1.85
+0.12
(+6.94%)
Pre-Market: 08:09
Karyopharm Therapeutics Gross Profit (Annual) : 139.82M for Dec. 31, 2025
Gross Profit (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 139.82M |
| December 31, 2024 | 138.89M |
| December 31, 2023 | 140.56M |
| December 31, 2022 | 151.24M |
| December 31, 2021 | 205.63M |
| December 31, 2020 | 104.41M |
| December 31, 2019 | 37.51M |
| December 31, 2018 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| December 31, 2012 | 0.512M |
| December 31, 2011 | 0.069M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| Madrigal Pharmaceuticals, Inc. | 900.75M |
| Relay Therapeutics, Inc. | 11.80M |
| ACADIA Pharmaceuticals, Inc. | 971.62M |
| Alnylam Pharmaceuticals, Inc. | 3.032B |
| Anika Therapeutics, Inc. | 63.81M |